RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial

Eddie Luidy Imada1, Diego Strianese2,3, Deepak P Edward2,4,5

  • 1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Insights

Orbitofacial neurofibromas (NFs) show distinct gene expression patterns, particularly in cell proliferation and immune pathways, compared to NFs elsewhere. These findings may explain their aggressive behavior and treatment challenges.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Neurofibromas (NFs) can cause significant disfigurement and functional impairment.
  • Orbitofacial NFs may exhibit greater local aggressiveness than NFs at other sites.
  • Malignant transformation is a potential risk for neurofibromas.

Purpose of the Study:

  • To identify molecular and biological differences between orbitofacial NFs and non-orbitofacial NFs.
  • To investigate potential genetic underpinnings for the observed clinical behavior of orbitofacial NFs.

Main Methods:

  • RNA-sequencing was performed on 10 orbitofacial NFs and 9 non-orbitofacial NFs.
  • Differential gene expression analysis was conducted to compare the two groups.
  • Gene expression data were compared with public databases of Schwann cell tumors and MPNST.

Main Results:

  • Enrichment of gene sets involved in cell proliferation, interferon, and immune pathways was observed in orbitofacial NFs.
  • Significant overlap in differentially expressed genes was found between orbitofacial vs. non-orbitofacial NFs and plexiform NF vs. MPNST.
  • Distinct gene expression profiles differentiate orbitofacial NFs from those at other anatomical locations.

Conclusions:

  • Orbitofacial neurofibromas possess unique gene expression signatures compared to NFs in other locations.
  • These molecular differences may contribute to the increased morbidity and treatment difficulty associated with orbitofacial NFs.
  • Further research is warranted to explore therapeutic strategies targeting these molecular distinctions.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.6K